Provided by Tiger Trade Technology Pte. Ltd.

Inozyme Pharma

4.00
0.0000
Volume:- -
Turnover:5.83M
Market Cap:259.66M
PE:-2.38
High:4.00
Open:4.00
Low:4.00
Close:4.00
52wk High:6.24
52wk Low:0.7210
Shares:64.92M
Float Shares:30.15M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6822
EPS(LYR):-1.6243
ROE:-141.69%
ROA:-48.45%
PB:8.17
PE(LYR):-2.46

Loading ...

Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Major Issues Report

8-K - Current report
Jul 19, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 28, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 19, 2022

Major Issues Report

8-K - Current report
Apr 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 12, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Major Issues Report

8-K - Current report
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2022

Major Issues Report

8-K - Current report